Patents by Inventor Fabienne Mathieu

Fabienne Mathieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin D metabolite
    Patent number: 9746483
    Abstract: The invention concerns a process for the production of a hybridoma, and of a monoclonal antibody or fragments thereof able to recognize 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: August 29, 2017
    Assignee: DIASOURCE IMMUNOASSAYS S.A.
    Inventors: Michel Anciaux, Fabienne Mathieu, Frederic Lin, Martin Poncelet
  • PROCESS FOR THE PRODUCTION OF A HYBRIDOMA AND ANTIBODY OBTAINED THEREFROM, ABLE TO RECOGNIZE MORE THAN ONE VITAMIN D METABOLITE
    Publication number: 20170067916
    Abstract: The invention concerns a process for the production of a hybridoma, and of a monoclonal antibody or fragments thereof able to recognize 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
    Type: Application
    Filed: May 11, 2015
    Publication date: March 9, 2017
    Inventors: Michel Anciaux, Fabienne Mathieu, Frederic Lin, Martin Poncelet
  • PROCESS FOR THE PRODUCTION OF A HYBRIDOMA AND ANTIBODY OBTAINED THEREFROM, ABLE TO RECOGNIZE MORE THAN ONE VITAMIN D METABOLITE
    Publication number: 20150346224
    Abstract: The invention concerns a process for the production of a hybridoma, and of a monoclonal antibody or fragments thereof able to recognize 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
    Type: Application
    Filed: May 11, 2015
    Publication date: December 3, 2015
    Inventors: Michel Anciaux, Fabienne Mathieu, Frederic Lin, Martin Poncelet
  • PROCESS FOR THE PRODUCTION OF A HYBRIDOMA AND ANTIBODY OBTAINED THEREFROM, ABLE TO RECOGNIZE MORE THAN ONE VITAMIN D METABOLITE
    Publication number: 20110097733
    Abstract: The invention concerns a process for the production of a hybridoma, and of a monoclonal antibody or fragments thereof able to recognize 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
    Type: Application
    Filed: October 26, 2010
    Publication date: April 28, 2011
    Inventors: Michel Anciaux, Fabienne Mathieu, Frédéric Lin, Martin Poncelet
  • Microspheres for the controlled release of water-soluble substances and process for preparing them
    Patent number: 5609886
    Abstract: Microspheres which are a matrix of a biocompatible and biodegradable polymer which is soluble in an organic solvent which is immiscible in water, within which a water-soluble substance is uniformly distributed, and wherein the residual level of toxic solvent in the microspheres is lower than 1.5% by weight, progressively and continuously releases the substance over a period of at least 8 days when the microspheres are placed in an aqueous physiological environment, with a reduced or substantially absent first phase of accelerated release. A process for producing such microspheres is provided.
    Type: Grant
    Filed: July 26, 1995
    Date of Patent: March 11, 1997
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Henri Wantier, Fabienne Mathieu, Marc Baudrihaye, Dominique Delacroix
  • Preparation of microparticles for controlled release of water-soluble substances
    Patent number: 5478564
    Abstract: The subject of the present invention is a process for preparing microparticles of the microsphere type of a water-soluble substance and a biocompatible and biodegradable polymer controlling the kinetics of release of the said substance consisting of a matrix of the said polymer within which the said water-soluble substance is regularly dispersed, characterized in thata) the said polymer is dissolved in a first volatile organic solvent immiscible with water,b) the said water-soluble substance is dissolved in a second solvent which is miscible with the said first solvent, is a solvent for the polymer, and miscible with water,c) the solution of the said substance and the solution of the said polymer are mixed,d) an organic phase of the polymer and of the said substance is obtained which is then emulsified in an immiscible dispersant medium consisting of an aqueous phase containing an emulsifying agent,e) the two solvents are then removed from the microspheres being formed with stirring, the first solvent being r
    Type: Grant
    Filed: June 17, 1993
    Date of Patent: December 26, 1995
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Henri Wantier, Fabienne Mathieu, Marc Baudrihaye, Dominique Delacroix